Real‐life effectiveness of iGlarLixi (insulin glargine 100 U/mL and lixisenatide) in people with type 2 diabetes according to prior insulin use

Ähnliche Einträge

• Effectiveness and safety of insulin glargine 300 U/mL in insulin‐naïve individuals according to diabetes duration: Results from the REALI European pooled data analysis
  von: Pierre Gourdy, et al.
  Veröffentlicht: (2024)
• Efficacy and safety of switching to iGlarLixi from premixed insulins in people with type 2 diabetes: The Soli‐ SWITCH study
  von: Martin Haluzík, et al.
  Veröffentlicht: (2025)
• Insulin therapy DE ‐ intensificAtion with iGlarLixi : A phase 4, open‐label, parallel‐group randomised controlled trial
  von: Peter Novodvorský, et al.
  Veröffentlicht: (2025)
• The efficacy and safety of insulin glargine 100 U/mL + lixisenatide versus insulin degludec + insulin aspart in Chinese people with type 2 diabetes suboptimally controlled with oral antidiabetic drugs: The Soli‐D randomized controlled trial
  von: Yiming Mu
  Veröffentlicht: (2024)
• Safety and clinical effectiveness of iGlarLixi in people with type 2 diabetes mellitus in Mexico
  von: Juan Rosas‐Guzman, et al.
  Veröffentlicht: (2025)